Abstract:Recently, a growing focus has been on identifying critical mechanisms in neurological diseases that trigger a cascade of events, making it easier to target them effectively. One such mechanism is the inflammasome, an essential component of the immune response system that plays a crucial role in disease progression. The NLRP3 (nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain containing 3) inflammasome is a subcellular multiprotein complex that is widely expressed in the central nervous system (CNS) and can be activated by a variety of external and internal stimuli. When activated, the NLRP3 inflammasome triggers the production of proinflammatory cytokines interleukin-1β (IL-1β) and interleukin-18 (IL-18) and facilitates rapid cell death by assembling the inflammasome. These cytokines initiate inflammatory responses through various downstream signaling pathways, leading to damage to neurons. Therefore, the NLRP3 inflammasome is considered a significant contributor to the development of neuroinflammation. To counter the damage caused by NLRP3 inflammasome activation, researchers have investigated various interventions such as small molecules, antibodies, and cellular and gene therapy to regulate inflammasome activity. For instance, recent studies indicate that substances like micro-RNAs (e.g., miR-29c and mR-190) and drugs such as melatonin can reduce neuronal damage and suppress neuroinflammation through NLRP3. Furthermore, the transplantation of bone marrow mesenchymal stem cells resulted in a significant reduction in the levels of pyroptosis-related proteins NLRP3, caspase-1, IL-1β, and IL-18. However, it would benefit future research to have an in-depth review of the pharmacological and biological interventions targeting inflammasome activity. Therefore, our review of current evidence demonstrates that targeting NLRP3 inflammasomes could be a pivotal approach for intervention in neurological disorders.

Role of NLRP3 inflammasome in central nervous system diseases

Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders.

NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies

Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update

Targeting NLRP3 inflammasome for neurodegenerative disorders

The NLRP3 inflammasome: contributions to inflammation-related diseases

The role of NLRP6 in the development and progression of neurological diseases

CNS and CNS Diseases in Relation to Their Immune System

Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics

The Potential of NLRP3 Inflammasome As a Therapeutic Target in Neurological Diseases.

The Role of the Effects of Autophagy on NLRP3 Inflammasome in Inflammatory Nervous System Diseases

Targeting NLRP3 Inflammasomes: A Trojan Horse Strategy for Intervention in Neurological Disorders

NLRP1 inflammasome in neurodegenerative disorders: From pathology to therapies

NLRP3 Inflammasome: Activation, Regulation, and Role in Diseases

NLRP3 Inflammasome and Inflammatory Diseases

Mesenchymal stem cells (MSCs) and MSC-derived exosomes in animal models of central nervous system diseases: Targeting the NLRP3 inflammasome

Role of the NLRP3 inflammasome in autoimmune diseases

Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders

Focus on the Role of NLRP3 Inflammasome in Diseases

NLRP Inflammasomes in Health and Disease.